Development of a cellular high-content, immunofluorescent HBV core assay to identify novel capsid assembly modulators that induce the formation of aberrant HBV core structures

MLA

Danielle Peeters, et al. “Development of a Cellular High-Content, Immunofluorescent HBV Core Assay to Identify Novel Capsid Assembly Modulators That Induce the Formation of Aberrant HBV Core Structures.” Journal of Virological Methods, vol. 293, July 2021, p. 114150. EBSCOhost, https://doi.org/10.1016/j.jviromet.2021.114150.

APA

Danielle Peeters, Sarah Sauviller, Emmanuel Gustin, Peter Vermeulen, Jan Martin Berke, Dirk Wuyts, Frederik Pauwels, Koen Vandyck, Steffen Jaensch, & Karen Vergauwen. (2021). Development of a cellular high-content, immunofluorescent HBV core assay to identify novel capsid assembly modulators that induce the formation of aberrant HBV core structures. Journal of Virological Methods, 293, 114150. https://doi.org/10.1016/j.jviromet.2021.114150

Chicago

Danielle Peeters, Sarah Sauviller, Emmanuel Gustin, Peter Vermeulen, Jan Martin Berke, Dirk Wuyts, Frederik Pauwels, Koen Vandyck, Steffen Jaensch, and Karen Vergauwen. 2021. “Development of a Cellular High-Content, Immunofluorescent HBV Core Assay to Identify Novel Capsid Assembly Modulators That Induce the Formation of Aberrant HBV Core Structures.” Journal of Virological Methods 293 (July): 114150. doi:10.1016/j.jviromet.2021.114150.